Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

Patricia holds her Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She also served as a PhD student research assistant in the Laboratory of Doctor David A. Fidock, Department of Microbiology & Immunology, Columbia University, New York.

April 7, 2017April 7, 2017

Diabetes Can Predict Prostate Cancer in BPH Patients Undergoing HoLEP, Study Suggests

News

Diabetes may predict high-risk prostate cancer in men with benign prostatic hyperplasia (BPH) undergoing treatment with Holmium laser enucleation of the prostate, according to a new Japanese study. Known as ... Read more

January 30, 2017

Blocking Specific Hormone Shows Promise in Mice with Prostate Inflammation

News

Blocking activity of growth hormone-releasing hormone (GHRH) shows beneficial effects in mice with inflammation-induced prostate enlargement. This finding suggests that this strategy may be clinically useful in the treatment of benign prostatic hyperplasia ... Read more

January 20, 2017

Simultaneous Use of Alpha-blockers and Anticholinergics Better for PBH Than Ad-on Approach, Study Says

News

Simultaneous use of alpha-blockers and anticholinergics is a better way to treat those with Benign Prostatic Hyperplasia (BPH) and lower urinary tract symptoms than administering the therapies one after the ... Read more

September 23, 2016

Laser Technique Seen in Case Study to Ably Treat Enlarged Prostate in BPH Patient

News

A minimally invasive technique called holmium laser enucleation of the prostate (HoLEP) may be effective alternative to open prostatectomy in men with large prostate glands, according to a case report by researchers at Casey ... Read more

August 12, 2016

Diagnosis of Prostate Cancer Requires Tests Beyond Total PSA Value

News

Researchers recently determined that total levels of the prostate specific antigen (PSA) protein are not sufficient enough for evaluating and distinguishing between prostate cancer and other prostate diseases, such as ... Read more

June 7, 2016

Inhibition of TLR4 Signaling May Decrease BPH Chronic Inflammation, According to Study

News

Novel therapeutic targeting of TLR4 signaling pathway may halt chronic inflammation leading to benign prostate hyperplasia (BPH), according to a study, “LPS/TLR4 Signaling Enhances TGF-β Response Through Downregulating BAMBI During ... Read more

May 24, 2016May 24, 2016

Prosterol Appears Effective in Reducing BPH-related Enzyme, According to Study

News

Researchers determined that Prosterol — a novel saw palmetto supercritical CO2 extract (SPSE) — reduces the benign prostatic hyperplasia (BPH)-related enzyme 5α-reductase isoform II as effectively as standard therapies. The study, “Determination ... Read more

May 18, 2016May 18, 2016

BPH Genetic Profiling in Animal Model Identifies New Genes Relevant for Disease Development

News

Researchers identified genes and pathways involved in the development of benign prostatic hyperplasia (BPH), using a rat model for the disease. The study, “Molecular classification of benign prostatic hyperplasia: A gene ... Read more

April 27, 2016April 27, 2016

Naftopidil Reported in Japanese Study to Be an Effective Drug Treatment for LUTS

News

The drug naftopidil improves benign prostatic hyperplasia (BPH)-associated urinary tract symptoms by modulating the plasma levels of adrenaline, according to the study, “Influence of Naftopidil on Plasma Monoamine Levels and Lower ... Read more

April 22, 2016April 22, 2016

BPH Patients’ Urinary Retention Improves with Botox Injection in Bladder Neck: a Case Report

News

Administrating botulinum toxin A (Botox) directly into the neck of the bladder can alleviate BPH patients’ symptoms of urinary retention. according to a study, “Botulinum Toxin A Injection in the Bladder Neck: ... Read more